Research infrastructure services to enable R&I addressing main challenges and EU priorities
Quick Facts
Ready to Apply?
Get a personalized assessment of your eligibility and application strategy
See in 5 min if you're eligible for Research infrastructure services to enable R&I addressing main challenges and EU priorities offering max €45.0M funding💰 Funding Details
Funding Description
What the Grant Finances
* Primary purpose: Provision of trans-national, remote and/or virtual access to existing, state-of-the-art research-infrastructure services that directly address one of the four thematic areas (advanced biotechnology & biomanufacturing; novel radionuclides; future climate modelling; new aviation fuels & combustion technologies).
* Eligible cost categories
* Access provision units (may be reported as Horizon Europe unit costs) – incl. users’ travel & subsistence if on-site.
* Scientific/technical user support & ad-hoc training.
* Activities that harmonise, customise or digitally upgrade existing services (short-term R&D only; no long-term instrumentation development).
* Actions that streamline access procedures, integrate data with EOSC and ensure FAIR data stewardship.
* Outreach to target communities (incl. industry/SMEs & Widening countries).
Budget & Funding Rate
* Indicative EU contribution per project: up to €45 million.
* Funding rate: 100 % of eligible direct costs + 25 % flat-rate indirect costs (HORIZON-AG MGA).
* Total topic envelope: Not published; expect 3–5 grants to ensure coverage of all four areas.
Eligibility Snapshot
* Consortium must include:
* At least one ESFRI Landmark or ERIC (or legal host) as a beneficiary.
* A minimum of three independent legal entities from three different EU / Associated Countries (Horizon Europe RIA rule).
* Research infrastructures of European interest offering complementary services; third-country RIs fundable only if they provide unique capabilities.
* Special eligibility: Legal entities in AU, BR, CA, CL, IN, JP, MX, NZ, KR, SG, CH, US that offer access are *exceptionally* eligible for EU funding.
* Access provision requirement: Proposals must contain a concrete access programme (on-site, remote and/or virtual) and list the installations, services and number of access units offered.
* Single-stage call: Opens 06 May 2025, deadline 18 Sep 2025, 17:00 CET (Brussels time).
Non-fundable Activities
* Long-term R&D for new instruments, large-scale construction or major upgrades.
* Pure networking or research projects without substantial access provision.
---
At a Glance
| Item | Detail |
|------|--------|
| Call ID | HORIZON-INFRA-2025-01-SERV-02 |
| Action type | HORIZON-RIA |
| Max. EU funding | €45 M per grant |
| Areas | 1) Advanced biotech & biomanufacturing 2) Novel radionuclides 3) Climate modelling 4) New aviation fuels |
| Mandatory annexes | List of services/installations & access units; ERIC support letter (if applicable); Ethics & data-management sections |
📊 At a Glance
🇪🇺 Strategic Advantages
EU-Wide Advantages & Opportunities for Call HORIZON-INFRA-2025-01-SERV-02
Overview
This topic finances trans-national and/or virtual access to top-class Research Infrastructures (RIs) in four strategic areas. Operating at EU level unlocks advantages that simply cannot be matched by stand-alone national projects. The key EU-wide opportunities are detailed below and then broken down per thematic Area.
1. Single Market Access (450 + million citizens)
• Results feed directly into EU-wide value chains – e.g. biotech ingredients for food/pharma, radionuclide-based diagnostics, sustainable aviation fuel (SAF) supply, climate-data based services.
• Common EU certification pathways (EMA, EASA, CE-marking, REACH, etc.) allow clinical products, fuels or digital services validated in the project to circulate freely without re-testing in 27 Member States.
• Public procurement directives (e.g. Green Public Procurement, Innovation Procurement) create fast-track demand for validated sustainable solutions, multiplying market uptake.
2. Cross-Border Collaboration & Knowledge Exchange
• Mandatory involvement of at least one ESFRI Landmark/ERIC fosters pan-European consortia that pool complementary facilities and expertise (e.g. EU-IBISBA nodes, ACTRIS super-sites, PRISMAP reactors, DNW wind-tunnels).
• Trans-national user access budgets are fully eligible costs, removing the main financial barrier for researchers and SMEs in Widening countries to use world-leading RIs.
• Project-embedded training schools and mobility open career paths and strengthen the ERA talent pool.
3. EU Policy Alignment
• Direct contribution to flagship policies:
– European Green Deal & Fit-for-55 (SAF, climate models, biotech bio-based processes).
– EU Industrial & Bioeconomy Strategies (Area 1 biomanufacturing).
– SAMIRA Action Plan & Europe’s Beating Cancer (Area 2 radionuclides).
– European Climate Law, Destination Earth & Adaptation Mission (Area 3 climate models).
– ReFuelEU Aviation & Hydrogen Strategy (Area 4).
• Alignment boosts political visibility and increases chances of follow-up investment from Recovery & Resilience Facility, Cohesion Funds, CEF-Energy/Transport and national plans.
4. Regulatory Harmonisation
• Development and mutual recognition of SOPs, metrology standards and data formats across national RI nodes reduces duplication and accelerates certification/authorisation timelines.
• Connection to European Open Science Cloud (EOSC) ensures FAIR data and compliance with GDPR/AI Act, giving legal certainty for industry users.
5. Access to the EU Innovation Ecosystem
• Gateway to >300 ESFRI/ERIC facilities, 25+ KIC hubs (EIT) and 800+ Digital Innovation Hubs.
• Synergies with EuroHPC petascale systems (LUMI, Leonardo) for Areas 3-4; with EIC Pathfinder/Transition funds to spin off high-risk results; and with InvestEU for scale-up financing.
• JRC labs act as neutral reference and policy interface, easing translation of technical results into EU standards and legislation.
6. Funding Synergies & Leverage
• Horizon Europe funding rate (100 % direct + 25 % overhead) can be combined with:
– Digital Europe (data spaces, HPC).
– LIFE & Innovation Fund (demonstration of low-carbon fuels, bio-based processes).
– ERA-NETs / Cofund partnerships (e.g. Clean Aviation, Circular Bio-based Europe).
– ERDF/Interreg for infrastructure upgrades in widening regions.
• Proper synergy planning satisfies EC’s cumulative funding rules and maximises ROI.
7. Scale & Societal Impact
• Single-entry-point RI networks drastically reduce fragmentation, enabling industrial users to test, validate and certify at EU scale within one grant.
• Standardised access statistics, KPIs and open data contribute to authoritative IPCC assessments, EU climate indicators, EASA SAF certification pool and EMA dossiers.
• Long-term sustainability model based on user fees & service catalogues underpins ERA-wide RI landscape.
---
Area-Specific Opportunities
Area 1 – Advanced Biotechnology & Biomanufacturing
• Position EU-IBISBA as the continental “one-stop shop” for design-build-test-learn bioprocessing.
• Create EU-level bioprocess data lake aligned with Bioeconomy Strategy, enabling AI-driven optimisation and downstream exploitation under Data Act.
• Fast-track alignment with EFSA & EMA guidance for novel food, ATMPs and bio-pharma, smoothing access to EU market.
Area 2 – Novel Radionuclides & Facilities
• Consolidate PRISMAP into a permanent European Radionuclide Infrastructure, mirroring US DOE Isotope Programme, ensuring sovereign supply chains.
• Joint clinical translation platform accelerates multicentre trials under EU Clinical Trials Regulation, expanding patient reach.
• Support emerging SME radiopharma sector by providing GMP-grade isotopes under harmonised EU Pharmacopeia specs.
Area 3 – Climate Modelling & Impact
• Exploit EuroHPC machines and Copernicus Climate Change Service to deliver Euro-regional AR6+ simulations compliant with ESGF/EOSC standards.
• Provide evidence for National Energy & Climate Plans (NECPs) and EU Taxonomy reporting, creating immediate policy pull.
• Enable climate-service spin-offs targeting agriculture, insurance and urban planning markets across EU.
Area 4 – New Aviation Fuels & Combustion Technologies
• Leverage pan-EU test-rig network to complete ASTM D4054 Tier 2.5 datasets, a prerequisite for global SAF market entry.
• Support Clean Aviation JU demonstrators and link with SESAR for integrated fuel/operational optimisation.
• Facilitate harmonised safety standards in collaboration with EASA & EUROCONTROL, easing certification across Member States.
---
Actionable Recommendations for Applicants
1. Build a balanced consortium (ESFRI/ERIC + SMEs + Widening partners) and secure a JRC letter of support.
2. Allocate ≥60 % of budget to direct access provision to satisfy topic focus.
3. Integrate an EOSC-compatible data management plan and refer to European Charter for Access to RIs.
4. Map concrete funding synergies in work package on ‘Sustainability & Scale-up’ – cite specific calls (e.g. Clean Aviation, EIC Transition).
5. Develop an outreach plan targeting under-represented Member States and industry, using Enterprise Europe Network and EIT KICs.
By capitalising on these EU-wide advantages, consortia can deliver high-impact, policy-relevant results and position themselves for continued leadership in Europe’s knowledge-based economy.
🏷️ Keywords
Ready to Apply?
Get a personalized assessment of your eligibility and application strategy
See in 5 min if you're eligible for Research infrastructure services to enable R&I addressing main challenges and EU priorities offering max €45.0M funding